image: Immunologist Mireia Sospedra (back), Raquel Planas (front) and Paula Ojer-Tomas (middle), members of the team that identified a new candidate autoantigen in multiple sclerosis. This material relates to a paper that appeared in the Oct. 10, 2018, issue of Science Translational Medicine, published by AAAS. The paper, by R. Planas at University Hospital Zurich in Zürich, Switzerland; and colleagues was titled, "GDP-L-fucose Synthase is a CD4+ T cell-specific autoantigen in DRB3*02:02 multiple sclerosis patients." view more
Credit: Neuroimmunology and Multiple Sclerosis Research, University Hospital Zurich, Switzerland)